eNavvi and SandsRx Partner to Streamline Personalized Medicine

SAN JOSE, Calif. and WYLIE, Texas – January 19, 2026 – In a significant move to bridge the gap between digital health technology and specialized pharmaceutical care, prescription marketplace eNavvi has announced a strategic partnership with SandsRx, a prominent Texas-based compounding pharmacy. The collaboration aims to provide physicians with streamlined digital access to high-quality, custom-made medications for patients in rapidly growing fields like weight management, hormone replacement therapy (HRT), dermatology, and urology.

This alliance addresses a critical bottleneck in modern healthcare: while the demand for personalized medicine is surging, the process for prescribing and obtaining custom-compounded drugs has often remained cumbersome and fragmented. By integrating SandsRx’s accredited compounding facilities into its digital network, eNavvi is creating a more efficient pathway for doctors to order tailored treatments with confidence in their quality and safety.

The Digital Bridge for Custom Medications

At its core, the partnership represents the ongoing digital transformation of the pharmacy landscape. eNavvi operates as a digital intermediary, a marketplace designed to bring price transparency and simplicity to the prescription process. Its platform connects physicians' offices directly to a curated network of pharmacies, aiming to reduce the administrative workload that plagues many medical practices.

The addition of SandsRx adds a crucial layer of specialization. Compounding—the art and science of creating personalized medications for specific patient needs—is a complex field. It involves creating formulations that may not be commercially available, such as unique dosage strengths, allergen-free preparations, or different delivery forms like creams or sterile injectables. Traditionally, this process involves phone calls, faxes, and a significant amount of follow-up to ensure accuracy and availability.

By integrating SandsRx, eNavvi digitizes this workflow. Prescribers can now use a single platform to not only identify the need for a compounded solution but also to transmit the order to a vetted, high-quality provider. This move aligns with eNavvi's broader strategy of expanding its specialized network to become a comprehensive resource for independent medical practices.

"SandsRx brings a level of dedication to the eNavvi network that directly benefits our prescribers and their patients," said Dr. Simon Chang, CEO of eNavvi, in the official announcement. "SandsRx distinguishes itself through proactive administrative support and seamless patient communication. Adding SandsRx to our network ensures our prescribers have a partner who treats every order with urgency. They remove the complexity from compounding, making high-quality care accessible and stress-free."

Meeting Surging Demand for Tailored Treatments

The timing of this partnership is particularly noteworthy, as it coincides with unprecedented demand in the specific therapeutic areas it targets. The market for weight management drugs, for example, has exploded, leading to persistent shortages of popular commercial medications like GLP-1 agonists. This has driven many patients and providers to seek compounded alternatives. However, this trend has also brought increased regulatory scrutiny, making the choice of a reliable, compliant compounding pharmacy more critical than ever.

Similarly, the field of Hormone Replacement Therapy (HRT), including bioidentical hormones (BHRT), relies heavily on compounding to provide dosages and combinations tailored to an individual's specific hormonal needs. Patients often require adjustments that mass-produced products cannot accommodate. The ability for a physician to easily prescribe a custom-formulated BHRT cream or injectable from a trusted source is a significant advantage in delivering personalized wellness.

In dermatology and urology, compounding has long been a cornerstone of treatment for complex cases. Whether it's a unique combination of topical agents for a skin condition or a specialized formulation for erectile dysfunction, the ability to customize medication is key to achieving optimal patient outcomes. This partnership provides physicians in these specialties with a powerful tool to enhance their treatment capabilities.

Upholding Quality in a Scrutinized Field

While the demand for compounded drugs is high, so is the need for rigorous quality control. The compounding industry has faced periods of intense scrutiny regarding safety and efficacy. This is where the credentials of a partner like SandsRx become a cornerstone of the eNavvi offering.

SandsRx is a PCAB-accredited pharmacy. The Pharmacy Compounding Accreditation Board (PCAB) provides a voluntary but stringent quality assurance program that certifies a compounding pharmacy meets the highest national standards. This accreditation signals a commitment to patient safety that goes beyond basic state licensing requirements.

Furthermore, SandsRx adheres to the United States Pharmacopeia (USP) standards, specifically USP for non-sterile compounding (e.g., creams and capsules) and USP for sterile compounding (e.g., injectables). These standards govern every aspect of the compounding process, from personnel training and facility design to ingredient sourcing and final product testing. For prescribers using the eNavvi platform, this means they can order complex sterile injectables for weight loss or HRT with a high degree of confidence that the products are prepared in a controlled and safe environment. This emphasis on verifiable quality is a key differentiator in a crowded and often confusing market.

Redefining the Prescriber and Patient Experience

Ultimately, the collaboration between eNavvi and SandsRx is designed to improve the experience for both the physician and the end patient. For medical practices, the primary benefit is a significant reduction in administrative friction. Instead of practice staff spending hours verifying pharmacy credentials, negotiating pricing, and tracking down orders, the eNavvi platform promises a more streamlined, transparent, and reliable process. This frees up valuable time that can be redirected toward direct patient care.

For patients, the benefits are twofold. First is improved access. They are more likely to receive the personalized medications their doctors believe are best for them, without the logistical hurdles that can sometimes prevent prescriptions from being filled. Second, and perhaps more importantly, is the assurance of quality. By curating its network to include PCAB-accredited partners like SandsRx, eNavvi acts as a gatekeeper for quality, giving patients peace of mind that their custom medications are not just personalized, but also safe.

As healthcare continues its evolution toward a more personalized and digitally integrated model, partnerships like this one are becoming essential. They represent a fusion of technological efficiency and clinical excellence, creating an ecosystem where obtaining specialized, high-quality medical treatments becomes a seamless part of the patient care journey. This move by eNavvi and SandsRx sets a new benchmark for how digital platforms can empower prescribers and enhance patient access to the next generation of medicine.